Curative resection for locally advanced sigmoid colon cancer using neoadjuvant chemotherapy with FOLFOX plus panitumumab: A case report

Highlights • Systemic or adjuvant chemotherapy is internationally accepted as a standard treatment for patients with metastatic or postoperative colorectal cancer, respectively. • Moreover, recent studies have demonstrated that preoperative chemotherapy improves the outcome of patients with CRC with...

Full description

Saved in:
Bibliographic Details
Published in:International journal of surgery case reports 2017-01, Vol.31, p.128-131
Main Authors: Tomizawa, Kenji, Miura, Yuji, Fukui, Yudai, Hanaoka, Yutaka, Toda, Shigeo, Moriyama, Jin, Inoshita, Naoko, Ozaki, Yukinori, Takano, Toshimi, Matoba, Shuichiro, Kuroyanagi, Hiroya
Format: Article
Language:English
Subjects:
Case Report
Neoadjuvant chemotherapy
Panitumumab
Sigmoid colon cancer
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Systemic or adjuvant chemotherapy is internationally accepted as a standard treatment for patients with metastatic or postoperative colorectal cancer, respectively. • Moreover, recent studies have demonstrated that preoperative chemotherapy improves the outcome of patients with CRC with liver metastases. • However, little is known about the effect and safety of preoperative FOLFOX and panitumumab combined chemotherapy for initially unresectable, locally advanced colon cancer without distant metastases.
ISSN:2210-2612
2210-2612
DOI:10.1016/j.ijscr.2017.01.027